Comparison of PD‐L1 detection assays and corresponding significance in evaluation of diffuse large B‐cell lymphoma
Sixia Huang(Peking University), Ting Li(Fudan University), Yalin Zheng(University of Liverpool), Wei Wang(The University of Texas MD Anderson Cancer Center), Ying Wang(Hebei Medical University), Liang Li(Peking University First Hospital), Dong Li(Peking University), Lin Nong(Peking University), Jumei Liu(Xiamen University), Xin Li(Peking University), Bo Zhang(King University)
Cited by 17
Related Papers
Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice
|Nature Genetics|2011|230
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
|Blood|2016|191
Identification of FOXM1 as a specific marker for triple‑negative breast cancer
|International Journal of Oncology|2018|64